Private Equity and Venture Capital professionals, academics and students to congregate for one-day conference on February 9
The Venture Capital & Private Equity Club, a student club at Harvard Business School, will hold its 20th Annual Venture Capital & Private Equity Conference February 9, 2014, on the Harvard Business School campus in Boston. As one of the largest and most anticipated student-run conferences, the one-day event will provide a forum for private equity and venture capital professionals, academics and students to reflect on the evolving landscape of the industry today.
Headlining this year's conference will be the following distinguished keynote speakers: David Rubenstein, Founder of The Carlyle Group; Joe Baratta, Global Head of Private Equity for Blackstone; and Chamath Palihapitiya, Founder of Social Capital and Former Vice President of Facebook.
This year introduces several new exciting panel topics, including Investing in Africa, Family Offices, Corporate Venture Capital, and Women in Private Equity. All panels will be comprised of a blend of institutional investment managers, fund general partners, advisors, and intermediaries, each with extensive experience in the private equity and venture capital industries. Panelists will draw from various firms such as The Blackstone Group, The Starwood Capital Group, Goldman Sachs, General Catalyst and many more. To view the full schedule of events and to register to attend, please visit: http://2014.vcpeconference.com/
"We are thrilled to host the 20th Annual Venture Capital & Private Equity Conference at Harvard Business School," said Barbara Rauber, Harvard Business School MBA Class of 2014 and Co-President of the Venture Capital & Private Equity Conference. "It is an honor to welcome the leading members of the private equity and venture capital community to our conference once again and we look forward to a conference that will further the discussion on the evolving landscape of the alternative investment industry, where it is today and most importantly where it is going."
"The panels we've put together this year address a range of today's most relevant topics in alternative investments, from growth equity investing and fundraising to geography specific investment opportunities," said Alex Kleiner, Harvard Business School MBA Class of 2014 and Co-President of the Venture Capital & Private Equity Conference. "We hope to initiate a broad range of debates about the key trends affecting the industry today and into the future."
Prominent members of the financial community sponsor the conference, including Kirkland & Ellis LLP, Goodwin Procter LLP, Ernst and Young and BackBay Communications. The Charity Partner for the event is Expect Miracles Foundation. Media sponsors include AltAssets, Buyouts Magazine, Dow Jones, Mergers & Acquisitions, Pitchbook News, The Deal, and Venture Capital Journal.
About the Venture Capital & Private Equity Club
The Venture Capital & Private Equity (VCPE) Club is a student-run club at Harvard Business School. The Club is committed to providing its members with career and educational opportunities focused on the venture capital and private equity sectors. The VCPE Club's goal is to provide members with an opportunity to learn about venture capital and private equity, interact with some of the industry's leading players, and meet fellow students who share similar interests. The Annual Venture Capital & Private Equity Conference is the Club's marquee event and is one of the largest student-run conferences on campus. Each year the VCPE Club brings in high profile venture capitalists, LBO and private equity investors from around the world. For more information on the VCPE Club please visit http://www.hbsvcpe.com/.
Jen Dowd, 617-556-9982 ext 225
About Expect Miracles Foundation
Expect Miracles Foundation is one of the leading advocates in the fight against cancer within the financial services industry. Proceeds benefit cancer patient care initiatives nationwide and cutting edge research at the Belfer Institute for Applied Cancer Science at the Dana-Farber Cancer Institute.